American Lithium Announces Financial and Operating Highlights for First Quarter Ended May 31, 2024
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | Nasdaq:AMLI […]
LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024
BURLINGTON, Mass., July 16, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second […]
TSX News -
ECN Capital Schedules Q2-2024 Conference Call
TORONTO, July 16, 2024 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or “the Company”) announced today that […]
Vital Energy Schedules Second-Quarter 2024 Earnings Release and Conference Call
TULSA, OK, July 16, 2024 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy” or the “Company”) will report […]
LM Funding America, Inc. Provides Monthly Operational and Bitcoin Mining Update for Month Ended June 30, 2024
TAMPA, FL, July 16, 2024 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a […]
TSX News -
Calfrac Well Services Ltd. Reschedules 2024 Second Quarter Earnings Release, Conference Call and Webcast to August 1, 2024
CALGARY, Alberta, July 16, 2024 (GLOBE NEWSWIRE) — Calfrac Well Services Ltd. (“Calfrac”) (TSX:CFW) now intends to release its 2024 […]
ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients […]
Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical […]
